Trial Profile
Prasugrel Antiplatelet Efficacy Compared to Clopidogrel adjuSted Loading Doses in Patients With High Platelet Reactivity After Stenting
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Blood platelet disorders; Embolism and thrombosis
- Focus Pharmacodynamics
- Acronyms PECS-HPR
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Dec 2011 New trial record